Swedbank’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-45,505
Closed -$428K 708
2023
Q1
$428K Sell
45,505
-198,200
-81% -$2.34M ﹤0.01% 676
2022
Q4
$2.98M Hold
243,705
0.01% 553
2022
Q3
$3.02M Sell
243,705
-149,042
-38% -$2.61M 0.01% 561
2022
Q2
$7.71M Buy
392,747
+8,373
+2% +$198K 0.02% 460
2022
Q1
$10M Hold
384,374
0.02% 441
2021
Q4
$11M Buy
384,374
+250
+0.1% +$7.78K 0.02% 450
2021
Q3
$12.2M Buy
384,124
+35,211
+10% +$1.18M 0.02% 435
2021
Q2
$12.1M Buy
348,913
+231,411
+197% +$7.63M 0.02% 443
2021
Q1
$3.46M Buy
+117,502
New +$3.61M 0.01% 592

Other funds holding ELAN

Swedbank's ELAN Position: Q2 2023 in Review

Swedbank sold out of Elanco Animal Health (ELAN) in Q2 2023, closing a stake of 45,505 shares — an estimated $428K sold.

Swedbank first reported a position in ELAN in Q1 2021 and held it in 9 quarters. The position peaked at $12.2M in Q3 2021. 352 funds tracked by Wall St. Rank hold ELAN as of Q2 2023.

  • Swedbank reported no remaining Elanco Animal Health position as of Q2 2023 after selling out during the quarter.
  • Swedbank sold 45,505 Elanco Animal Health shares in Q2 2023, an estimated $428K.
  • Swedbank first reported a position in Elanco Animal Health in Q1 2021 and held it in 9 quarters.
  • Swedbank's Elanco Animal Health position peaked at $12.2M in Q3 2021.
  • 352 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2023.

Based on Swedbank's 13F filing for Q2 2023, filed 6 Dec 2024.